Microbead-selected CD56+ cells showed no significant difference in their killing of K562 cells with that of the same quantity of non-selected CD56+ cells (Supplementary Materials Figure S2a), which suggested that CD56+ cells were the principal cell type to mediate tumor cell killing. This evidence concerns the gene NCAM1 and neoplasm.